Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
1976-6-2
|
pubmed:abstractText |
Eight patients had pyoderma gangrenosum. They were given a phendimetrazine tartrate derivative, clofazimine (Lamprene [Britain]), which is a chemotherapeutic agent used mainly in certain mycobacterial infections and which also has phagocytosis-enhancing properties. The effect of this drug was remarkably good, with rapid healing of the lesions commencing 3 to 14 days after treatment was started. The mechanism for the effect of clofazimine in pyoderma gangrenosum is not known.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
0003-987X
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
112
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
344-9
|
pubmed:dateRevised |
2008-3-17
|
pubmed:meshHeading |
pubmed-meshheading:1259447-Adult,
pubmed-meshheading:1259447-Aged,
pubmed-meshheading:1259447-Clofazimine,
pubmed-meshheading:1259447-Drug Evaluation,
pubmed-meshheading:1259447-Female,
pubmed-meshheading:1259447-Gangrene,
pubmed-meshheading:1259447-Humans,
pubmed-meshheading:1259447-Male,
pubmed-meshheading:1259447-Middle Aged,
pubmed-meshheading:1259447-Pyoderma
|
pubmed:year |
1976
|
pubmed:articleTitle |
Clofazimine. A new agent for the treatment of pyoderma gangrenosum.
|
pubmed:publicationType |
Journal Article,
Case Reports
|